# Introduction # Case Presentation # Discussion # Conclusions
Please provide 4-6 keywords.
1. Autoimmune Dermatoses 2. Bacterial Infections 3. Contact and Occupational Dermatitis 4. Corrective, Aesthetic and Cosmetic Dermatology 5. Cultural Dermatology 6. Cutaneous Tumors and Oncology 7. Dermatological Surgery 8. Dermatology and Internal Medicine, incl. Skin Manifestations of Systemic Diseases 9. Dermatopathology 10. Dermato-venereology, Sexually Transmitted Infections, HIV/ AIDS 11. Diagnostic Procedures 12. Economics in Dermatology, Ethics in Dermatology 13. Environmental Dermatology 14. Epidemiology 15. Fungal Infections 16. Hair Disorders/ Diseases 17. Inflammatory Dermatoses 18. Nail Disorders/ Diseases 19. Oral Mucosa and other Skin-Adjacent Mucous Membranes 20. Paediatric Dermatology 21. Parasitic Diseases and Infestations 22. Pharmacology and Skin-Related Toxicology 23. Photobiology, Phototherapy & Photosensitivity Diseases 24. Phyto/ Phytophoto Dermatitis 25. Pigmentary Disorders 26. Pregnancy-Related Dermatoses 27. Pruritus, Urticaria, Angioedema 28. Psychodermatology 29. Quality of Life 30. Therapy- Systemic Treatments, Topical Therapy 31. Viral Infections 32. Wounds, Chronic Wounds, Wound Healing, Ulcers 33. Miscellaneous
Previous presentations/ publication of the work does not disqualify a paper, but this must be clearly stated when submitting.
Successful submissions will be acknowledged by email to the corresponding author. All further correspondence will also be via emails, therefore, ensure you provide a valid email address.
A delegate is eligible to submit an abstract after preliminary registration in the conference website without proceeding to payments. Author is expected to complete the payments within two weeks of notification of the acceptance. Failure to do so, will automatically remove the abstract from the abstract book and e-posters. Registration rate will be the amount which will prevail at the time of doing the payments. (Not the rates applicable at the time of preliminary registration).
The evaluation of the abstract (acceptance or rejection) will be done following a number of criteria, including: 1. Is the content interesting, informative, novel or important? 2. Are the methods valid, the results relevant and the conclusions justified by the data? 3. Are the data presented with clarity and with appropriate structure?
MODE OF PRESENTATION
The Scientific Committee will decide on the mode of presentation and that will be informed with the acceptance of the paper. All e-posters will be displayed on wide screen in a prominent area during the entire period of the scientific sessions.
CHANGE OF CATEGORIES
Applicants should think carefully about which submission category best suits their abstract since only one may be chosen. During the review process, the Scientific Committee reserves the right to reassign any submission to another category if they determine it is more applicable to the content of the abstract.
SPELLING & GRAMMAR
Please check spelling, capitalization of words and grammar carefully. Direct reproduction from your electronically submitted abstract text means that any errors in spelling, grammar or scientific data will be reproduced in the abstract book as submitted. Errors will not be amended by the organizers.
DRUG NAMES/ PHARMACEUTICAL COMPANY NAMES
Commercial drug names may not be used. Drugs should be referred to by the active substance or pharmacological designation. Pharmaceutical company names should not be included in the body of the abstract.
COPYRIGHT & PUBLICATION
1. Submission of an abstract implies that it has been approved by all listed authors. 2. The Scientific Committee reserves the right to make the final decision concerning the form of presentation. 3. Accepted abstracts will be published on the official e-version of the abstract book, which will be distributed at the congress. 4. Submission of an abstract constitutes your consent to publication (e.g. Congress website, Abstract book, Programmes). 5. Abstracts will be published as submitted. Errors will not be amended by the organizers.
Subscribe to our Newsletter